RARA and acute promyelocytic leukemia: It was also established that some fusion proteins found in hematopoietic malignancies, including p210BCR-ABL and PML-RARα which are drivers for chronic myeloid leukemia and acute promyelocytic leukemia, respectively, can be degraded through MA [92,93,94] or other mechanisms [95,96].